Publications View
BCL-2 inhibition: stemming the tide of myeloid malignancies.
ABT-199: taking dead aim at BCL-2.
Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer.
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Authors: Authors: Davids MS, Deng J, Wiestner A, Lannutti BJ, Wang L, Wu CJ, Wilson WH, Brown JR, Letai A.
Blood
View full abstract on Pubmed
Blood
View full abstract on Pubmed
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.
Authors: Authors: Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM, Deangelo DJ, Frattini MG, Letai A.
Cell
View full abstract on Pubmed
Cell
View full abstract on Pubmed
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.
Authors: Authors: Ercan D, Xu C, Yanagita M, Monast CS, Pratilas CA, Montero J, Butaney M, Shimamura T, Sholl L, Ivanova EV, Tadi M, Rogers A, Repellin C, Capelletti M, Maertens O, Goetz EM, Letai A, Garraway LA, Lazzara MJ, Rosen N, Gray NS, Wong KK, Jänne PA.
Cancer Discov
View full abstract on Pubmed
Cancer Discov
View full abstract on Pubmed
Targeting the B-cell lymphoma/leukemia 2 family in cancer.
BCL2 suppresses PARP1 function and nonapoptotic cell death.
Authors: Authors: Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, Fung H, Brown JR, Shapiro GI, Letai A, Weinstock DM.
Cancer Res
View full abstract on Pubmed
Cancer Res
View full abstract on Pubmed
BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1a.
Authors: Authors: Rodriguez DA, Zamorano S, Lisbona F, Rojas-Rivera D, Urra H, Cubillos-Ruiz JR, Armisen R, Henriquez DR, Cheng EH, Letek M, Vaisar T, Irrazabal T, Gonzalez-Billault C, Letai A, Pimentel-Muiños FX, Kroemer G, Hetz C.
EMBO J
View full abstract on Pubmed
EMBO J
View full abstract on Pubmed
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.
Authors: Authors: Azab AK, Quang P, Azab F, Pitsillides C, Thompson B, Chonghaile T, Patton JT, Maiso P, Monrose V, Sacco A, Ngo HT, Flores LM, Lin CP, Magnani JL, Kung AL, Letai A, Carrasco R, Roccaro AM, Ghobrial IM.
Blood
View full abstract on Pubmed
Blood
View full abstract on Pubmed